focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Replacement of SHIRE

20 Dec 2018 14:44

RNS Number : 1681L
Morgan Stanley & Co. Int'l plc
20 December 2018
 

AMENDMENT Section (2b) 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

12 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 5p ordinary

 PURCHASES

 711,428

 45.5900 GBP

 45.2950 GBP

 

 5p ordinary

 SALES

 406,682

 45.6300 GBP

 45.0600 GBP

 

 5p ordinary

 PURCHASES

 949,088

 57.6165 USD

 57.2433 USD

 

 5p ordinary

 SALES

 270,475

 57.6956 USD

 56.9010 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 ADR

 CFD

 LONG

 5

 172.7200 USD

 

 ADR

 CFD

 SHORT

 7,500

 172.4220 USD

 

 5p ordinary

 CFD

 LONG

 1,891

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 13,927

 45.4228 GBP

 

 5p ordinary

 CFD

 LONG

 966

 45.4246 GBP

 

 5p ordinary

 CFD

 LONG

 1,550

 45.4396 GBP

 

 5p ordinary

 CFD

 LONG

 8,467

 45.4543 GBP

 

 5p ordinary

 CFD

 LONG

 2

 45.4950 GBP

 

 5p ordinary

 CFD

 LONG

 20,523

 45.5423 GBP

 

 5p ordinary

 CFD

 LONG

 23,488

 45.5423 GBP

 

 5p ordinary

 CFD

 LONG

 521

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 492

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 140

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 581

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 112

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 115

 45.5729 GBP

 

 5p ordinary

 CFD

 LONG

 33

 45.5729 GBP

 

 5p ordinary

 CFD

 SHORT

 12,360

 45.4000 GBP

 

 5p ordinary

 CFD

 SHORT

 12,361

 45.4000 GBP

 

 5p ordinary

 CFD

 SHORT

 862

 45.4000 GBP

 

 5p ordinary

 CFD

 SHORT

 1

 45.4085 GBP

 

 5p ordinary

 CFD

 SHORT

 387

 45.4085 GBP

 

 5p ordinary

 CFD

 SHORT

 68

 45.4541 GBP

 

 5p ordinary

 CFD

 SHORT

 1,468

 45.4570 GBP

 

 5p ordinary

 CFD

 SHORT

 295

 45.4650 GBP

 

 5p ordinary

 CFD

 SHORT

 394

 45.4793 GBP

 

 5p ordinary

 CFD

 SHORT

 558

 45.4874 GBP

 

 5p ordinary

 CFD

 SHORT

 228

 45.4926 GBP

 

 5p ordinary

 CFD

 SHORT

 22,386

 45.5011 GBP

 

 5p ordinary

 CFD

 LONG

 10,604

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 17,500

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 17,500

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 9,981

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 9,867

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 9,924

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 166,807

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 79,723

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 17,500

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 37,238

 45.4000 GBP

 

 5p ordinary

 CFD

 LONG

 4,693

 56.9010 USD

 

 5p ordinary

 CFD

 LONG

 89,151

 57.1903 USD

 

 5p ordinary

 CFD

 LONG

 39,173

 57.2005 USD

 

 5p ordinary

 CFD

 SHORT

 6,000

 45.3466 GBP

 

 5p ordinary

 CFD

 SHORT

 2,432

 45.3466 GBP

 

 5p ordinary

 CFD

 SHORT

 376,644

 45.4000 GBP

 

 5p ordinary

 CFD

 SHORT

 3,658

 45.5011 GBP

 

 5p ordinary

 CFD

 SHORT

 163

 45.5045 GBP

 

 5p ordinary

 CFD

 SHORT

 173,631

 45.5200 GBP

 

 5p ordinary

 CFD

 SHORT

 173,631

 45.5200 GBP

 

 5p ordinary

 CFD

 SHORT

 155,000

 57.2433 USD

 

 5p ordinary

 CFD

 SHORT

 350,000

 57.2433 USD

 

 5p ordinary

 CFD

 SHORT

 120,000

 57.2433 USD

 

 5p ordinary

 CFD

 SHORT

 50,000

 57.2863 USD

 

 5p ordinary

 CFD

 SHORT

 211,688

 57.4416 USD

 

 5p ordinary

 CFD

 SHORT

 10,000

 57.6165 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 20 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERTMBITMBITBBP
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.